Walgreens Boots Alliance (WBA) Misses Q3 EPS by 8c, Lowers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Burry doubles down on Nebius short after stock surges 34% on earnings
- Total darkness, then sunset as full eclipse wows spectators in Spain
TD Cowen on Walgreens Boosts Alliance (WBA): 'continued challenges in retail pharmacy'
June 27, 2024 8:51 AM EDTTD Cowen analyst Charles Rhyee reiterated a Buy rating and $35.00 price target on Walgreens Boosts Alliance (NASDAQ: WBA).
The analyst comments "F3Q adj EPS $0.63 missed cons $0.69. WBA narrowed FY24 guide to $2.80-$2.95 (from $3.20-$3.35), which assumes continued challenges in retail pharmacy.... More
RBC Capital on Walgreens (WBA): 'ongoing consumer weakness and pressure on pharmacy margin'
June 27, 2024 8:28 AM EDTRBC Capital analyst Anton Hie reiterated a Sector Perform rating and $22.00 price target on Walgreens Boosts Alliance (NASDAQ: WBA).
The analyst comments "WBA posted fiscal 3Q24 earnings slightly below expectations driven by ongoing consumer weakness and pressure on pharmacy margin, partially offset by another quarter of good International performance and positive EBITDA contribution from U.S. Healthcare. Management lowered its adjusted EPS guidance by $0.40 at the midpoint, or -12%... More
